Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Dynavax Stock Is Jumping Today

TheMotleyFool

0 0

Shares of Dynavax Technologies (NASDAQ: DVAX) are jumping today, up 7.5% as of 11:23 a.m. EST, after the company announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) recommended approval for hepatitis B vaccine Heplisav-B.

CHMP's positive recommendation is great news for Dynavax because it bodes well for the company's prospects of winning European approval for Heplisav-B. The hepatitis B vaccine has been on the market in the U.S. since 2017.

Image source: Getty Images.

Source Fool.com

Like: 0

DVAX

Share